UPC — Universe Pharmaceuticals Share Price
Last trade - 00:00- $87.73m
- $74.70m
- $32.31m
- 82
- 29
- 77
- 66
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.24 | ||
| Price to Tang. Book | 0.24 | ||
| Price to Free Cashflow | 8.91 | ||
| Price to Sales | 0.3 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -8.92% | ||
| Return on Equity | -14.34% | ||
| Operating Margin | -10.92% | ||
Financial Summary
| Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 33.23 | 30.7 | 47.98 | 40.14 | 32.31 | n/a | n/a | 2.53% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +2.04 | -2.58 | +65.72 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
Directors
- Last Annual
- September 30th, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- December 11th, 2019
- Public Since
- March 23rd, 2021
- No. of Employees
- 225
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 3,645,974
- Address
- 265 Jingjiu Avenue, JI'AN, 343100
- Web
- http://www.universe-pharmacy.com/
- Phone
- +86 7968403309
- Contact
- Tina Xiao
- Auditors
- /s/ YCM CPA, Inc
Upcoming Events for UPC
Similar to UPC
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Aadi Bioscience
NASDAQ Capital Market
Acasti Pharma
NASDAQ Capital Market
Agriforce Growing Systems
NASDAQ Capital Market
Aptorum
NASDAQ Capital Market
FAQ
As of Today at 17:57 UTC, shares in Universe Pharmaceuticals are trading at $2.63. This share price information is delayed by 15 minutes.
Shares in Universe Pharmaceuticals last closed at $2.63 and the price had moved by -2.59% over the past 365 days. In terms of relative price strength the Universe Pharmaceuticals share price has underperformed the S&P500 Index by -22.49% over the past year.
There is no consensus recommendation for this security.
Universe Pharmaceuticals does not currently pay a dividend.
Universe Pharmaceuticals does not currently pay a dividend.
Universe Pharmaceuticals does not currently pay a dividend.
To buy shares in Universe Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.63, shares in Universe Pharmaceuticals had a market capitalisation of $9.59m.
Here are the trading details for Universe Pharmaceuticals:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: UPC
Based on an overall assessment of its quality, value and momentum Universe Pharmaceuticals is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Universe Pharmaceuticals. Over the past six months, its share price has outperformed the S&P500 Index by +75.69%.
As of the last closing price of $2.63, shares in Universe Pharmaceuticals were trading +52.62% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Universe Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.63.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Universe Pharmaceuticals' directors